RxDoctor Payments Data

Victoria Hicks, PA

Physician Assistant · Flemingsburg, KYNPI 1316347701

Payments from drug & device makers

$404in general payments, 2019–2025

Across 22 payments — averaging $18.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$124
  • Lilly USA, LLC$73
  • GSK$60
  • Exact Sciences$36
  • Novo Nordisk$34
  • Axsome Therapeutics, Inc.$25
  • plus $51 from 3 others

What the payments were for

  • Food & beverage$404100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$404 in reported general payments places this provider in the 50th percentile of 1,448 physician assistant providers in Kentucky.

See all physician assistant providers in Kentucky

Medicare billing

Part B allowed, 2024
$3,862
Medicare patients
51
Services billed
216

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide60$56,296
FarxigaDapagliflozin Propanediol52$33,983
TrulicityDulaglutide21$28,592
MounjaroTirzepatide23$24,207
LinzessLinaclotide17$18,110
JanuviaSitagliptin Phosphate19$14,878
Soliqua 100-33Insulin Glargine/Lixisenatide17$14,498
Trelegy ElliptaFluticasone/Umeclidin/Vilanter16$10,962
Breo ElliptaFluticasone/Vilanterol12$7,832
Lantus SolostarInsulin Glargine,hum.Rec.Anlog42$6,405
XareltoRivaroxaban18$5,560
DexilantDexlansoprazole12$3,606
Albuterol Sulfate HfaAlbuterol Sulfate94$3,107
SynthroidLevothyroxine Sodium30$2,486
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate15$1,790

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$34$56,29660 claims
Lilly USA, LLCTrulicity, Mounjaro$73$52,79944 claims
AstraZenecaFarxiga$18$33,98352 claims
AbbVieLinzess, Synthroid$124$20,59647 claims
GSKTrelegy Ellipta, Breo Ellipta$60$18,79528 claims
Sanofi-aventis U.S. LLCSoliqua 100-33$12$14,49817 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 1,448 physician assistant providers in Kentucky.

Other physician assistant in Flemingsburg

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →